The results support the development of Sanionas proprietary formulation called Tesomet, which combines tesofensine with another compound and is currently in Phase 2 trials for rare eating disorders
The preclinical evidence is often strong but the path from animal models to approved human therapies is long, expensive, and uncertain
8.7 Hepatic Impairment M.V.I
Every batch manufactured is rigorously tested to ensure complete compound stability across varying environmental parameters, allowing for repeatable baseline tracking regarding: S-Adenosylmethionine (SAM) to S-Adenosylhomocysteine (SAH) Ratios: Evaluating how the preservation of methyl donors influences wider epigenetic DNA methylation lines
Reference: Dimet-Wiley AL, Latham CM, Brightwell CR, Neelakantan H, Keeble AR, Thomas NT, Noehren H, Fry CS, Watowich SJ (2024)
What Are the Benefits of B12 IV Infusions